Fibrinolysis, new concepts and new mechanisms: fibrinolytic microvesicles and fibrinolytic crosstalk: Fibrinolysis, new concepts and new mechanisms

Abstract : Thrombus lysis is the consequence of a restricted number of reactions localised to the surface of fibrin. A functional defect or an insufficient fibrinolytic response may lead to thrombosis with severe or fatal clinical consequences, e.g. myocardial infarction and ischemic stroke. Despite this clinical exigency and a real progress in the knowledge of the different components of this system (plasminogen and its activators, inhibitors and receptors), its functional evaluation still remains a challenge in haemostasis. The absolute requirement of a template for molecular assembly of plasminogen and its activators (tissue- and urokinase-type plasminogen activators: tPA and uPA) restricts the formation of plasmin and protects its activity onto the surface of, respectively, fibrin and cells. In contrast, plasmin and tPA released from the clot during its lysis are immediately neutralised by their respective inhibitors α2-antiplasmin and plasminogen activator inhibitor 1, PAI-1). It seems therefore almost impossible to detect fibrinolytic activity in plasma with methods currently in use. Because of its unavailability, it is also impossible to measure the degree of fibrinolysis directly on the clot. Notwithstanding, it was recently discovered that circulating membrane microvesicles might be indicators of the fibrinolytic response to an inflammatory or prothrombotic process. These cell-derived fibrinolytic microvesicles bear at their membrane the plasminogen activators expressed by the parent cell: tPA from endothelial cells and uPA from leukocytes. These molecules are localised at the membrane surface and have the capacity to activate plasminogen into plasmin in situ. Moreover, it was recently discovered that these microvesicles might participate in a new mechanism of plasmin formation requiring a cross-talk between two different surfaces. In this fibrinolytic cross-talk one of the surfaces bear plasminogen (fibrin, extracellular matrix or platelets) whereas the other surface carry the plasminogen activator, typically leukocyte-derived microvesicles bearing uPA. These new actors and concepts in plasminogen activation represent hitherto unknown pathways in our comprehension of fibrinolysis and potential novel biomarkers in clinical practice.
Type de document :
Communication dans un congrès
AMEH. Comunicacion Celular y Homeostasis Vascular, Apr 2013, Mazatlan, Mexico. Nieto Editores, 14 (Supl 1), pp.S55-S64, 2013
Liste complète des métadonnées

Littérature citée [65 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00851467
Contributeur : Eduardo Angles-Cano <>
Soumis le : mercredi 14 août 2013 - 12:46:54
Dernière modification le : jeudi 11 janvier 2018 - 06:21:13
Document(s) archivé(s) le : mercredi 5 avril 2017 - 20:44:51

Fichier

RdH2013_14_supl_1_S55Fibrinoly...
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

  • HAL Id : inserm-00851467, version 1

Collections

Citation

Eduardo Angles-Cano, Laurent Plawinski. Fibrinolysis, new concepts and new mechanisms: fibrinolytic microvesicles and fibrinolytic crosstalk: Fibrinolysis, new concepts and new mechanisms. AMEH. Comunicacion Celular y Homeostasis Vascular, Apr 2013, Mazatlan, Mexico. Nieto Editores, 14 (Supl 1), pp.S55-S64, 2013. 〈inserm-00851467〉

Partager

Métriques

Consultations de la notice

617

Téléchargements de fichiers

214